Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Janssen Research & Development, Llc, explained in plain language.
This study tests whether a new drug combination (TAR-200 plus cetrelimab) can help people with muscle-invasive bladder cancer who cannot or choose not to have their bladder removed. About 518 participants will receive either the drug combo or standard chemoradiation. The goal is …
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 17, 2026 06:52 UTC